Guardant Health (NASDAQ:GH), a $5.49 billion market cap healthcare company, announced a significant step in its financial strategy, reaching an agreement to exchange a portion of its convertible notes ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating ...
We recently compiled a list of the 12 Best Booming Stocks to Invest in Now. In this article, we are going to take a look at ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on February 6, 2025, it ...
Craig-Hallum analyst William Bonello maintained a Buy rating on Guardant Health (GH – Research Report) today. The company’s shares closed ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results ...
Learn more about whether Guardant Health, Inc. or Premier, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
SG Americas Securities LLC decreased its position in Guardant Health, Inc. (NASDAQ:GH – Free Report) by 43.1% during the 4th ...
Shares of Guardant Health, Inc. (NASDAQ:GH – Get Free Report) have been given an average rating of “Buy” by the fifteen analysts that are covering the company, MarketBeat.com reports.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results